Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P180036/S034

OPTIMIZER SMART Mini IPG

Impulse Dynamics (Usa), Inc. · Decision date Nov 19, 2025

FDA DECISIONP180036/S034

What did the FDA approve?

FDA records P180036/S034 as a supplement to PMA P180036, with the supplement type “135 Review Track For 30-Day Notice”. The recorded decision is approval, dated Nov 19, 2025.

FDA approval order statement

a process change for epoxy headers of OPTIMIZER implantable pulse generators
Regulatory pathway
PMA supplement
Supplement type
135 Review Track For 30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Nov 19, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P180036/S034
Regulatory pathway
PMA supplement
Product code
QFV
Decision code
APPR
Decision date
Nov 19, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable pulse generator.

Product code
QFV
FDA device class
3

For the original device and its historical approval scope, see PMA P180036. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P180036 · Original PMA

    OPTIMIZER Smart System

  2. P180036/S034 received

    Application receipt date recorded by FDA.

  3. P180036/S034 · FDA decision

    135 Review Track For 30-Day Notice

  4. P180036/S043 · Related supplement

    OPTIMIZER Smart and Smart Mini

  5. P180036/S046 · Related supplement

    OPTIMIZER Smart and Smart Mini System

Timeline entries are records held by MedtechLedger for P180036. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P180036

Product / regulatory recordCompanyPathwayDecision dateSource
Impulse Dynamics (Usa), Inc.PMA approvalMar 21, 2019FDA
Impulse Dynamics (Usa), Inc.PMA supplementApr 10, 2026FDA
Impulse Dynamics (Usa), Inc.PMA supplementMay 13, 2026FDA
Impulse Dynamics (Usa), Inc.PMA supplementSep 24, 2026FDA
Impulse Dynamics (Usa), Inc.PMA supplementOct 14, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Impulse Dynamics (Usa), Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
50 Lake Center Executive Pkwy., 401 Rte. 73 N, Bldg. 50 Suite 100, Marlton, NJ, 08053

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records